Satya Siva Kishan Yalamarty

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 26

Top Topics

Hyaluronic Acid

Top Venues

Research square

Drug delivery and translational research

Journal of personalized medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Satya Siva Kishan Yalamarty, Nina Filipczak, Tanvi Pathrikar, Colin Cotter, Janaína Artem Ataide, Ed Luther, Swarali Paranjape, Vladimir Torchilin
Evaluation of mAb 2C5-modified dendrimer-based micelles for the co-delivery of siRNA and chemotherapeutic drug in xenograft mice model. Drug delivery and translational research (2024)
Satya Siva Kishan Yalamarty, Nina Filipczak, Tanvi Pathrikar, Colin Cotter, Janaína Artem Ataide, Ed Luther, Swarali Paranjape, Vladimir Torchilin
Evaluation of mAb 2C5-modified dendrimer-based micelles for the co-delivery of siRNA and chemotherapeutic drug in xenograft mice model. Drug delivery and translational research (2024)
Satya Siva Kishan Yalamarty, Nina Filipczak, Tanvi Pathrikar, Colin Cotter, Janaína Artem Ataide, Ed Luther, Swarali Paranjape, Vladimir Torchilin
Evaluation of mAb 2C5-modified dendrimer-based micelles for the co-delivery of siRNA and chemotherapeutic drug in xenograft mice model. Drug delivery and translational research 14 (8) (2024)
Satya Siva Kishan Yalamarty, Nina Filipczak, Tanvi Pathrikar, Colin Cotter, Janaína Artem Ataide, Ed Luther, Swarali Paranjape, Vladimir Torchilin
Evaluation of mAb 2C5-modified dendrimer-based micelles for the co-delivery of siRNA and chemotherapeutic drug in xenograft mice model. Drug delivery and translational research 14 (8) (2024)
Satya Siva Kishan Yalamarty, Nina Filipczak, Tanvi Pathrikar, Colin Cotter, Janaína Artem Ataide, Ed Luther, Swarali Paranjape, Vladimir Torchilin
Evaluation of mAb 2C5-modified dendrimer-based micelles for the co-delivery of siRNA and chemotherapeutic drug in xenograft mice model. Drug delivery and translational research 14 (8) (2024)
Satya Siva Kishan Yalamarty, Nina Filipczak, Tanvi Pathrikar, Colin Cotter, Janaína Artem Ataide, Ed Luther, Swarali Paranjape, Vladimir Torchilin
Evaluation of mAb 2C5-modified dendrimer-based micelles for the co-delivery of siRNA and chemotherapeutic drug in xenograft mice model. Drug delivery and translational research (2024)
Satya Siva Kishan Yalamarty, Nina Filipczak, Tanvi Pathrikar, Colin Cotter, Janaína Artem Ataide, Ed Luther, Swarali Paranjape, Vladimir Torchilin
Evaluation of mAb 2C5-modified dendrimer-based micelles for the co-delivery of siRNA and chemotherapeutic drug in xenograft mice model. Drug delivery and translational research (2024)
Satya Siva Kishan Yalamarty, Nina Filipczak, Tanvi Pathrikar, Colin Cotter, Janaína Artem Ataide, Ed Luther, Swarali Paranjape, Vladimir Torchilin
Correction: Evaluation of mAb 2C5-modified dendrimer-based micelles for the co-delivery of siRNA and chemotherapeutic drug in xenograft mice model. Drug delivery and translational research (2024)
Satya Siva Kishan Yalamarty, Nina Filipczak, Tanvi Pathrikar, Colin Cotter, Janaína Artem Ataide, Ed Luther, Swarali Paranjape, Vladimir Torchilin
Evaluation of mAb 2C5-modified dendrimer-based micelles for the co-delivery of siRNA and chemotherapeutic drug in xenograft mice model. Research square (2023)
Satya Siva Kishan Yalamarty, Nina Filipczak, Tanvi Pathrikar, Colin Cotter, Janaína Artem Ataide, Swarali Paranjape, Vladimir Torchilin
Evaluation of mAb 2C5-modified dendrimer-based micelles for the co-delivery of siRNA and chemotherapeutic drug in xenograft mice model. Research square (2023)
Satya Siva Kishan Yalamarty, Nina Filipczak, Tanvi Pathrikar, Colin Cotter, Janaína Artem Ataide, Ed Luther, Swarali Paranjape, Vladimir Torchilin
Evaluation of mAb 2C5-modified dendrimer-based micelles for the co-delivery of siRNA and chemotherapeutic drug in xenograft mice model. Research square (2023)
Janaína Artem Ataide, Julia Cedran Coco, Érica Mendes Dos Santos, Viviane Lucia Beraldo-de-Araújo, Jéssica Ribeiro Alves Silva, Karine Cappuccio de Castro, André Moreni Lopes, Nina Filipczak, Satya Siva Kishan Yalamarty, Vladimir P Torchilin, Priscila Gava Mazzola
Co-Encapsulation of Drugs for Topical Application-A Review. Molecules (Basel, Switzerland) 28 (3) (2023)
Satya Siva Kishan Yalamarty, Nina Filipczak, Tanvi Pathrikar, Colin Cotter, Janaína Artem Ataide, Ed Luther, Swarali Paranjape, Vladimir Torchilin
Evaluation of mAb 2C5-modified dendrimer-based micelles for the co-delivery of siRNA and chemotherapeutic drug in xenograft mice model. Research square (2023)
Md Abdus Subhan, Farzana Parveen, Hassan Shah, Satya Siva Kishan Yalamarty, Janaína Artem Ataide, Valdimir P Torchilin
Recent Advances with Precision Medicine Treatment for Breast Cancer including Triple-Negative Sub-Type. Cancers 15 (8) (2023)
Satya Siva Kishan Yalamarty, Nina Filipczak, Tanvi Pathrikar, Colin Cotter, Janaína Artem Ataide, Ed Luther, Swarali Paranjape, Vladimir Torchilin
Evaluation of mAb 2C5-modified dendrimer-based micelles for the co-delivery of siRNA and chemotherapeutic drug in xenograft mice model. Research square (2023)
Md Abdus Subhan, Farzana Parveen, Nina Filipczak, Satya Siva Kishan Yalamarty, Vladimir P Torchilin
Approaches to Improve EPR-Based Drug Delivery for Cancer Therapy and Diagnosis. Journal of personalized medicine 13 (3) (2023)
Satya Siva Kishan Yalamarty, Nina Filipczak, Tanvi Pathrikar, Colin Cotter, Janaína Artem Ataide, Swarali Paranjape, Vladimir Torchilin
Evaluation of mAb 2C5-modified dendrimer-based micelles for the co-delivery of siRNA and chemotherapeutic drug in xenograft mice model. Research square (2023)
Satya Siva Kishan Yalamarty, Nina Filipczak, Tanvi Pathrikar, Colin Cotter, Janaína Artem Ataide, Ed Luther, Swarali Paranjape, Vladimir Torchilin
Evaluation of mAb 2C5-modified dendrimer-based micelles for the co-delivery of siRNA and chemotherapeutic drug in xenograft mice model. Research square (2023)
Satya Siva Kishan Yalamarty, Nina Filipczak, Xiang Li, Md Abdus Subhan, Farzana Parveen, Janaína Artem Ataide, Bharat Ashok Rajmalani, Vladimir P Torchilin
Mechanisms of Resistance and Current Treatment Options for Glioblastoma Multiforme (GBM). Cancers 15 (7) (2023)
Satya Siva Kishan Yalamarty, Nina Filipczak, Tanvi Pathrikar, Colin Cotter, Janaína Artem Ataide, Ed Luther, Swarali Paranjape, Vladimir Torchilin
Evaluation of mAb 2C5-modified dendrimer-based micelles for the co-delivery of siRNA and chemotherapeutic drug in xenograft mice model. Research square (2023)
Md Abdus Subhan, Farzana Parveen, Nina Filipczak, Satya Siva Kishan Yalamarty, Vladimir P Torchilin
Approaches to Improve EPR-Based Drug Delivery for Cancer Therapy and Diagnosis. Journal of personalized medicine 13 (3) (2023)
Md Abdus Subhan, Farzana Parveen, Nina Filipczak, Satya Siva Kishan Yalamarty, Vladimir P Torchilin
Approaches to Improve EPR-Based Drug Delivery for Cancer Therapy and Diagnosis. Journal of personalized medicine 13 (3) (2023)
Md Abdus Subhan, Farzana Parveen, Hassan Shah, Satya Siva Kishan Yalamarty, Janaína Artem Ataide, Valdimir P Torchilin
Recent Advances with Precision Medicine Treatment for Breast Cancer including Triple-Negative Sub-Type. Cancers 15 (8) (2023)
Janaína Artem Ataide, Julia Cedran Coco, Érica Mendes Dos Santos, Viviane Lucia Beraldo-de-Araújo, Jéssica Ribeiro Alves Silva, Karine Cappuccio de Castro, André Moreni Lopes, Nina Filipczak, Satya Siva Kishan Yalamarty, Vladimir P Torchilin, Priscila Gava Mazzola
Co-Encapsulation of Drugs for Topical Application-A Review. Molecules (Basel, Switzerland) 28 (3) (2023)
Janaína Artem Ataide, Julia Cedran Coco, Érica Mendes Dos Santos, Viviane Lucia Beraldo-de-Araújo, Jéssica Ribeiro Alves Silva, Karine Cappuccio de Castro, André Moreni Lopes, Nina Filipczak, Satya Siva Kishan Yalamarty, Vladimir P Torchilin, Priscila Gava Mazzola
Co-Encapsulation of Drugs for Topical Application-A Review. Molecules (Basel, Switzerland) 28 (3) (2023)
Satya Siva Kishan Yalamarty, Nina Filipczak, Xiang Li, Tanvi Vinod Pathrikar, Colin Cotter, Vladimir P Torchilin
Co-Delivery of siRNA and Chemotherapeutic Drug Using 2C5 Antibody-Targeted Dendrimer-Based Mixed Micelles for Multidrug Resistant Cancers. Pharmaceutics 14 (7) (2022)